Matrine improves 17α-ethinyl estradiol-induced acute cholestasis in rats

Hepatology Research

Volumn 39, Issue 11, 2009, Pages 1144-1149

  Zhao, Ying ^a,b   Zhai, Desheng ^c   He, Hui ^a   Liu, Junhua ^b   Li, Tingting ^a   Chen, Xijing ^a   Ji, Hui ^a  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

^b XINXIANG MEDICAL UNIVERSITY   (China)

^c CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Bile excretion; Ethinyl estradiol; Intrahepatic cholestasis; Matrine

Indexed keywords

BILE SALT; ETHINYLESTRADIOL; GLUCURONIDE; GLYCOCHOLIC ACID; KETOPROFEN; MATRINE; MULTIDRUG RESISTANCE PROTEIN 1; RHODAMINE 123; URSODEOXYCHOLIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BILE FLOW; BLOOD CHEMISTRY; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; INTRAHEPATIC CHOLESTASIS; LIVER PROTECTION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 73649130973     PISSN: 13866346     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1872-034X.2009.00557.x     Document Type: Article

References (23)

1. Rutherford Ae, Pratt D.S. Cholestasis and cholestatic syndromes. Curr Opin Gastroenterol 2006; 22: 209-14.
2. Paumgartner G, Beuers U. Ursodeoxycholic acid in cholestatic liver disease: mechanisms of action and therapeutic use revisited. Hepatology 2002; 36: 525-31.
3. Zapata R, Sandoval L, Palma J et al. Ursodeoxycholic acid in the treatment of intrahepatic cholestasis of pregnancy. A 12-year experience. Liver Int 2005; 25: 548-54.
4. Glantz A, Marschall HU, Lammert F et al. Intrahepatic cholestasis of pregnancy: a randomized controlled trial comparing dexamethasone and ursodeoxycholic acid. Hepatology 2005; 42: 1399-405.
5. Pusl T, Beuers U. Intrahepatic cholestasis of pregnancy. Orphanet J Rare Dis 2007; 2: 26.
6. Goulis J, Leandro G, Burroughs A.K. Randomised controlled trials of ursodeoxycholic-acid therapy for primary biliary cirrhosis: a meta-analysis. Lancet 1999; 354 (9184): 1053-60.
7. Gumucio JJ, Valdivieso V.D. Studies on the mechanism of the ethynylestradiol impairment of bile flow and bile salt excretion in the rat. Gastroenterology 1971; 61: 339-44.
8. Bossard R, Stieger B, O'Neill B et al. Ethinylestradiol treatment induces multiple canalicular membrane transport alterations in rat liver. J Clin Invest 1993; 91: 2714-20.
9. Lao Y. Clinical study of matrine injection on preventing liver function damage of anti-tumor drugs during chemotherapy of breast cancer. Zhong Yao Cai 2005; 28: 735-7.
10. Cheng H, Xia B, Zhang L et al. Matrine improves 2,4,6-trinitrobenzene sulfonic acid-induced colitis in mice. Pharmacol Res 2006; 53: 202-8.
11. Pei RJ, Xiao L, Fan XP et al. The effects of matrine on mouse immune functions. Hai Xia Yao Xue 1998; 10: 7-8.
12. Balistreri WF, Bezerra JA, Jansen P et al. Intrahepatic cholestasis: summary of an American Association for the Study of Liver Diseases single-topic conference. Hepatology 2005; 42: 222-35.
13. Zhao Y, Zhai D, Chen X, Yang J, Song X, He H et al. Ketoprofen glucuronidation and bile excretion in carbon tetrachloride and alpha-naphthylisothiocyanate induced hepatic injury rats. Toxicology 2007; 230 (2-3): 145-50.
14. Meunier CJ, Verbeeck R.K. Glucuronidation kinetics of R,Sketoprofen in adjuvant-induced arthritic rats. Pharm Res 1999; 16: 1081-6.
15. Bodo A, Bakos E, Szeri F, Varadi A, Sarkadi B. Differential modulation of the human liver conjugate transporters MRP2 and MRP3 by bile acids and organic anions. J Biol Chem 2003; 278: 23529-37.
16. Bossard R, Stieger B, O'Neill B et al. Ethinylestradiol treatment induces multiple canalicular membrane transport alterations in rat liver. J Clin Invest 1993; 91: 2714-20.
17. Stieger B, Fattinger K, Madon J et al. Drug- and estrogeninduced cholestasis through inhibition of the hepatocellular bile salt export pump (Bsep) of rat liver. Gastroenterology 2000; 118: 422-30.
18. Huang L, Smit JW, Meijer DK et al. Mrp2 is essential for estradiol-17beta(beta-D-glucuronide)-induced cholestasis in rats. Hepatology 2000; 32: 66-72.
19. Liu Y, Huang L, Hoffman T et al. MDR1 substrates/modulators protect against b-estradiol-17b-D-glucuronide cholestasis in rat liver. Cancer Res 1996; 56: 4992-7.
20. Mutoh K, Tsukahara S, Mitsuhashi J et al. Estrogenmediated post transcriptional down-regulation of P-glycoprotein in MDR1-transduced human breast cancer cells. Cancer Sci 2006; 97: 1198-204.
21. Simon FR, Fortune J, Iwahashi M et al. Ethinyl estradiol cholestasis involves alterations in expression of liver sinusoidal transporters. Am J Physiol 1996; 271 (6 Pt 1): G1043-52.
22. Sánchez Pozzi EJ, Crocenzi FA, Pellegrino JM et al. Ursodeoxycholate reduces ethinylestradiol glucuronidation in the rat: role in prevention of estrogen-induced cholestasis. J Pharmacol Exp Ther 2003; 306: 279-86.
23. Zhao Y, Zhai D, Chen X et al. Protective effect of glycyrrhizin and matrine on acute vanishing bile duct syndrome induced by alpha-naphthylisothiocyanate in rats. Hepatol Res 2007; 37: 143-51.